Location: Shanghai/Beijing

Reporting to: Head of Public Affairs & Market Access, China

ROLE PURPOSE

The Head of GenMed Value & Pricing is responsible for the end-to-end value and pricing strategy of Sanofi’s General Medicine (GM) portfolio in China—from early clinical development, evidence strategy, pricing, and reimbursement planning to NRDL national negotiation and lifecycle sustainability.

This role ensures that China’s General Medicine (GM)  access decisions are grounded in clinical value, government payer requirements, and China’s evolving policy ecosystem.

KEY RESPONSIBILITIES

1. Pricing & VBP Strategy

• Lead GM pricing strategy aligned with:
  • international reference considerations
  • local cost-effectiveness
  • hospital procurement dynamics
• Develop annual NRDL renewal strategies for GM products, including indication-level pricing logic, competitor mapping, payer negotiation insights
• Identify risks and opportunities from policy updates, including renewal rules, monitoring rules, and clinical pathway changes.
• Provide strategic response to national VBP waves, including risk assessment, competitive simulation, and post-VBP sustainability planning.
• Support pricing governance and cross-BU alignment.

2. Evidence Requirements (Chronic Disease Focus)

• Define evidence needs for chronic disease areas: adherence, long-term outcomes, epidemiology, and real-world disease burden.
• Partner with HEOR to produce payer-relevant dossiers for NRDL, provincial access, and pathway inclusion.
• Support GM-specific RWE designs for improving payer and clinical decision-making.

3. Cross-Functional Leadership & Team Management

• Lead and mentor a high-performing GM value & pricing team.
• Drive integrated access decision-making across functions and ensure disciplined execution.

QUALIFICATIONS

Experience

• 5+ years in market access, pricing, evidence strategy, or policy.
• Strong hands-on experience in NRDL.
• Leadership experience in high-stakes access decisions.

Capabilities

• Strategic thinking with strong analytical judgment.
• Advanced understanding of GM therapeutic areas and payer decision logic.
• Ability to influence senior stakeholders internally and externally.

Education

• Master’s degree or above (Public Health, Health Economics, Medical, Pharmacy).
• Fluency in English and Mandarin.